Bigger health companies: Good for Medicare, maybe not for others

from The Incidental Economist at http://bit.ly/V2Zwep on June 30, 2014 at 05:00PM The following appeared on The Upshot while I was on vacation (copyright 2014, The New York Times Company). Although Obamacare’s health insurance expansion has directly provided coverage to only about 4 percent of Americans, changes embedded in the Affordable Care Act could affect many more people, and not […]

Turns out telling people to “eat more fruits and vegetables” doesn’t work

from The Incidental Economist at http://bit.ly/1jCdOZ1 on June 30, 2014 at 12:30PM From the American Journal of Clinical Nutrition, “Increased fruit and vegetable intake has no discernible effect on weight loss: a systematic review and meta-analysis“: Background: A common dietary recommendation for weight loss, especially in lay public outlets, is to eat more fruit and […]

ACA, Uninsurance and American Cities

from Healthcare Economist at http://bit.ly/1iLeiBp on June 30, 2014 at 03:26AM The Affordable Care Act (ACA) increased the likelihood individuals have insurance by: (i) offering states money to expand Medicaid eligibility, and (ii) offering individuals subsidies to purchase insurance through newly created health insurance exchanges.  Did it work?  A Robert Wood Johnson report examines at […]

Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists

from Latest Results for Applied Health Economics and Health Policy at http://bit.ly/1nSSrFf on June 29, 2014 at 01:00AM Abstract Background A considerable proportion of patients with asthma remain uncontrolled or symptomatic despite treatment with a high dose of inhaled glucocorticosteroids (ICSs) and long-acting β2-agonists (LABAs). Tiotropium Respimat® added to usual care improves lung function, asthma […]

Here is something about the response to the Health Reform (the Affordable Care Act) I don’t get…

from health-policy-blog at http://bit.ly/1mouGSS on June 28, 2014 at 02:28AM So here is something that has perplexed me for a long time, watching the (largely successful) rollout of health reform (the Affordable Care Act). For months now, many very bright people (pundits, reporters, Legislators) have been fixated on one part of the Affordable Care Act […]

UPDATE: Layoffs continue in Missouri-near 1,000 layoffs in health sector since April 2013?

from health-policy-blog at http://bit.ly/1mouEud on June 27, 2014 at 11:56PM In an earlier post, I laid out data I have been accumulating from press reports on job layoffs in the health care sector, mostly affecting hospitals and health systems.  Today (6/27), 60 more layoffs were announced in Springfield (MO) by Ozarks Community Hospital.   Thus […]

Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis

from Latest Results for PharmacoEconomics at http://bit.ly/1pYRtdO on June 28, 2014 at 01:00AM Abstract Background Management of rheumatoid arthritis (RA) is characterised by a sequence of disease-modifying antirheumatic drugs (DMARDs) and biological response modifiers (BRMs). In most of the Western countries, the drug sequences are determined based on disease activity and treatment history of the […]

Willingness to Pay for Health Insurance Among HIV-Positive Patients in India

from Latest Results for Applied Health Economics and Health Policy at http://bit.ly/1wFzxHe on June 27, 2014 at 01:00AM Abstract Background Standard health insurance products in India currently exclude conditions related to HIV. Although antiretroviral (ARV) drugs are now publicly funded, the burden of treatment due to hospitalization on people living with HIV and AIDS (PLHIV) […]

Food Labeling Litigation: Exposing Gaps in the FDA’s Resources and Regulatory Authority

from Brookings: Topics – Health at http://bit.ly/TmAiWW on June 26, 2014 at 05:00PM Nicole Negowetti examines the recent spate of food labeling litigation and explores the reasons for this flood of lawsuits.  Negowetti argues that such litigation has exposed problems with the FDA’s regulatory oversight of food label­ing, and, more importantly, represents attempts by consumer […]

Food Labeling Litigation: Exposing Gaps in the FDA’s Resources and Regulatory Authority

from Brookings: Topics – Health at http://bit.ly/TmAiWW on June 26, 2014 at 05:00PM Nicole Negowetti examines the recent spate of food labeling litigation and explores the reasons for this flood of lawsuits.  Negowetti argues that such litigation has exposed problems with the FDA’s regulatory oversight of food label­ing, and, more importantly, represents attempts by consumer […]